| Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial AM Borobia, AJ Carcas, M Pérez-Olmeda, L Castaño, MJ Bertran, ... The Lancet 398 (10295), 121-130, 2021 | 441 | 2021 |
| Inhibiting inflammation with myeloid cell-specific nanobiologics promotes organ transplant acceptance MS Braza, MMT van Leent, M Lameijer, BL Sanchez-Gaytan, RJW Arts, ... Immunity 49 (5), 819-828. e6, 2018 | 218 | 2018 |
| Differential effects of the second SARS-CoV-2 mRNA vaccine dose on T cell immunity in naive and COVID-19 recovered individuals D Lozano-Ojalvo, C Camara, E Lopez-Granados, P Nozal, ... Cell reports 36 (8), 2021 | 111 | 2021 |
| The BCG vaccine for COVID-19: first verdict and future directions M Gonzalez-Perez, R Sanchez-Tarjuelo, B Shor, E Nistal-Villan, ... Frontiers in immunology 12, 632478, 2021 | 90 | 2021 |
| Intercompartmental Recombination of HIV-1 Contributes to env Intrahost Diversity and Modulates Viral Tropism and Sensitivity to Entry Inhibitors RJP Brown, PJ Peters, C Caron, MP Gonzalez-Perez, L Stones, ... Journal of virology 85 (12), 6024-6037, 2011 | 72 | 2011 |
| A conserved determinant in the V1 loop of HIV-1 modulates the V3 loop to prime low CD4 use and macrophage infection T Musich, PJ Peters, MJ Duenas-Decamp, MP Gonzalez-Perez, ... Journal of virology 85 (5), 2397-2405, 2011 | 64 | 2011 |
| Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue MP Gonzalez-Perez, O O'Connell, R Lin, WM Sullivan, J Bell, ... Retrovirology 9, 1-16, 2012 | 57 | 2012 |
| Human T-cell leukemia virus type I infection in various recipients of transplants from the same donor MP González-Pérez, L Muñoz-Juárez, FC Cárdenas, JJZ Imirizaldu, ... Transplantation 75 (7), 1006-1011, 2003 | 49 | 2003 |
| Rapid, scalable assessment of SARS-CoV-2 cellular immunity by whole-blood PCR M Schwarz, D Torre, D Lozano-Ojalvo, AT Tan, T Tabaglio, S Mzoughi, ... Nature biotechnology 40 (11), 1680-1689, 2022 | 38 | 2022 |
| Reactogenicity and immunogenicity of BNT162b2 in subjects having received a first dose of ChAdOx1s: initial results of a randomised, adaptive, phase 2 trial (CombiVacS) AM Borobia, AJ Carcas, M Pérez Olmeda, L Castaño, M Jesús Bertrán, ... | 38 | 2021 |
| Ultradeep single-molecule real-time sequencing of HIV envelope reveals complete compartmentalization of highly macrophage-tropic R5 proviral variants in brain and CXCR4-using … RL Brese, MP Gonzalez-Perez, M Koch, O O’Connell, K Luzuriaga, ... Journal of neurovirology 24, 439-453, 2018 | 31 | 2018 |
| Efficiency of bridging-sheet recruitment explains HIV-1 R5 envelope glycoprotein sensitivity to soluble CD4 and macrophage tropism O O'Connell, A Repik, JD Reeves, MP Gonzalez-Perez, B Quitadamo, ... Journal of virology 87 (1), 187-198, 2013 | 29 | 2013 |
| Variation in the biological properties of HIV-1 R5 envelopes: implications of envelope structure, transmission and pathogenesis MJ Duenas-Decamp, PJ Peters, A Repik, T Musich, MP Gonzalez-Perez, ... Future virology 5 (4), 435-451, 2010 | 23 | 2010 |
| HIV-1 R5 macrophage-tropic envelope glycoprotein trimers bind CD4 with high affinity, while the CD4 binding site on non-macrophage-tropic, T-tropic R5 envelopes is occluded B Quitadamo, PJ Peters, A Repik, O O'Connell, Z Mou, M Koch, ... Journal of virology 92 (2), 10.1128/jvi. 00841-17, 2018 | 21 | 2018 |
| HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages T Musich, O O’Connell, MP Gonzalez-Perez, CA Derdeyn, PJ Peters, ... Retrovirology 12, 1-13, 2015 | 21 | 2015 |
| Identification of emerging macrophage-tropic HIV-1 R5 variants in brain tissue of AIDS patients without severe neurological complications MP Gonzalez-Perez, PJ Peters, O O'Connell, N Silva, C Harbison, ... Journal of Virology 91 (20), 10.1128/jvi. 00755-17, 2017 | 20 | 2017 |
| CombiVacS Study Group Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled … AM Borobia, AJ Carcas, M Pérez-Olmeda, L Castaño, MJ Bertran, ... Lancet 398 (10295), 121-130, 2021 | 12 | 2021 |
| Infection of ectocervical tissue and universal targeting of T-cells mediated by primary non-macrophage-tropic and highly macrophage-tropic HIV-1 R5 envelopes PJ Peters, MP Gonzalez-Perez, T Musich, TA Moore Simas, R Lin, ... Retrovirology 12, 1-12, 2015 | 10 | 2015 |
| Development of potent cellular and humoral immune responses in long-term hemodialysis patients after 1273-mRNA SARS-CoV-2 vaccination M Gonzalez-Perez, M Montes-Casado, P Conde, I Cervera, J Baranda, ... Frontiers in Immunology 13, 845882, 2022 | 8 | 2022 |
| Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study J García-Pérez, M González-Pérez, MC de la Osa, AM Borobia, L Castaño, ... EClinicalMedicine 50, 2022 | 6 | 2022 |
